Multivariate analysis of HDL-C testing and lipid-lowering scripts in the stable target population in 2014
| Demographics | Estimated HDL-C tests | Lipid-lowering scripts | ||
| OR | (95% CI) | OR | (95% CI) | |
| Gender | ||||
| Female | 1 | Reference | 1 | Reference |
| Male | 1.03 | 1.02 to 1.04*** | 1.00 | 1.00 to 1.00 |
| Age group | ||||
| 18–34 | 1.23 | 1.13 to 1.32*** | 0.63 | 0.61 to 0.65*** |
| 35–44 | 1.15 | 1.11 to 1.19*** | 0.68 | 0.67 to 0.69*** |
| 45–54 | 1.03 | 1.01 to 1.05*** | 0.76 | 0.75 to 0.77*** |
| 55–64 | 1.00 | 0.99 to 1.02 | 0.83 | 0.83 to 0.84*** |
| 65–74 | 1.02 | 1.00 to 1.03** | 0.94 | 0.94 to 0.94*** |
| ≥75 | 1 | Reference | 1 | Reference |
| States | ||||
| NSW+ACT | 1 | Reference | 1 | Reference |
| VIC+TA | 1.00 | 0.99 to 1.02 | 1.00 | 1.00 to 1.00 |
| SA+NT | 0.88 | 0.87 to 0.90*** | 1.02 | 1.01 to 1.02*** |
| QLD | 0.99 | 0.98 to 1.01 | 1.00 | 0.99 to 1.00 |
| WA | 0.89 | 0.88 to 0.91*** | 0.99 | 0.99 to 1.00 |
**p<0.01; ***p<0.001.
ACT, Australia Capital Territory; HDL-C, high-density lipoprotein cholesterol; NSW, New South Wales; NT, Northern Territory; QLD, Queensland; SA, South Australia; TA, Tasmania; VIC, Victoria; WA, Western Australia.